Schedule 13D ownership disclosure
BlackRock Health Sciences Term
Common Shares, $0.001 par value · CUSIP: 09260E105
Event date: 2025-01-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Saba Capital Management, L.P.Reported CIK 0001510281
Shares: 20,750,913 · Class: 19.98%
- Boaz R. WeinsteinReported CIK 0001608233
Shares: 20,750,913 · Class: 19.98%
- Saba Capital Management GP, LLC
Shares: 20,750,913 · Class: 19.98%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001062993-25-000932
- Form type
- SCHEDULE 13D/A
- Filer
- BlackRock Health Sciences Term Trust
- CIK
- CIK 1785971
- Filed
- Jan 21, 2025
- Reporting period
- Jan 20, 2025
- Description
- Schedule 13D beneficial ownership